Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

TIBX, NHPR, OCLS, PAYX, AMSC - CRWEPicks.com Stock Highlight! Feb 9th 2011

signup3m

31.58% UP 31.58% UP 31.58% UP 31.58% UP 31.58% UP 31.58% UP

http://crwewallstreet.com/img/nhpr_logo_01.jpg

Have you found that access to affordable medical in the United States is an entitlement? Yet dependant upon a seemingly arbitrary matrix of things, and the government insurance packages which are available for the elderly, the permanently disabled, people who have failing kidneys, the actual impoverished and children from low-income individuals. But how poor must one be to be eligible varies from state to state and also from year to year. Workers at most of the large firms and many of hte small firms have been able to take advantage of group insurance plans negotiated by way of their employers. Although millions of people who are employed in low-paying service, retail or perhaps contracting jobs need to seek individual insurance plans, which may be unaffordable or maybe unavailable because of their healthcare histories. Others obtain insurance with insurance deductibles so high or insurance coverage limits so low that one bad crash or illness would lead them close to bankrupt. The need for affordable healthcare alternatives has never been greater.

National Health Partners, Inc. (National Health) (OTCBB:NHPR.OB) has achieved positive earnings for the quarter ended September 30, 2010 compared to a loss of $522,542 for the same period last year. Revenues for the 3rd quarter grew 12.3% over the same period last year. The Company attributes the net earnings to the significant cost-cutting initiatives taken over the past couple of quarters and which is continuing in the 4th quarter.

David M. Daniels, President and Chief Executive Officer of National Health Partners, stated: “I am thrilled to announce that we have finally achieved profitability. Due to the fact that our limited medical provider unexpectedly decided to exit the marketplace, we were unable to add any new CARExpress Plus limited medical sales during the 3rd quarter. Yet, despite this temporary setback, we were still able to substantially increase our revenue and reach profitability which is a testament to the underlying strength we have with our core CARExpress health discount programs. Although we achieved positive results in revenues and earnings, we anticipate much better results in 2011.”

National Health Partners, Inc.:

National Health Partners, Inc. is a national healthcare savings organization that provides discount healthcare membership programs to uninsured and underinsured people through a national healthcare savings network called “CARExpress.” CARExpress is one of the largest networks of hospitals, doctors, dentists, pharmacists and other healthcare providers in the country and is comprised of over 1,000,000 medical professionals that belong to such PPOs as CareMark and Aetna. The company’s primary target customer group is the 47 million Americans who have no health insurance of any kind.

More about NHPR at: www.nationalhealthpartners.com

http://crwewallstreet.com/img/line1.png

http://www.oculusis.com/images/Oculus-logo.gif

Oculus Innovative Sciences, Inc. (NASDAQ:OCLS), is a commercial healthcare company that designs, produces and markets safe and effective tissue care products based upon the Microcyn® Technology platform, which significantly reduces the need for antibiotics while reducing infections and accelerating healing. Several solutions derived from this platform have demonstrated, in a variety of research and investigational studies, the ability to treat a wide range of pathogens, including antibiotic-resistant strains of bacteria (including MRSA and VRE), viruses, fungi and spores; increase blood flow to the wound site; and reduce both inflammation and pain while assisting in faster wound closure. The company’s headquarters are in Petaluma, California, with manufacturing operations in the United States and Latin America.

http://pennyomega.com/img/ocls_highlight.jpg

Oculus Innovative Sciences, Inc. (NASDAQ:OCLS), a commercial healthcare company that designs, produces and markets safe and effective tissue care products based upon the Microcyn® Technology platform, announced it had received a new FDA 510(k) clearance for its uniquely formulated Microcyn-based Epicyn™ HydroGel. Under the supervision of a healthcare professional, it is indicated to manage and relieve the burning, itching and pain experienced with various types of dermatoses, including atopic dermatitis and radiation dermatitis. Epicyn HydroGel may also be used to relieve the pain of first- and second-degree burns and can help to relieve dry waxy skin by maintaining a moist wound and skin environment, which is beneficial to the healing process. The hydrogel is a shelf-stable hypochlorous acid formulation based on the company’s proprietary Microcyn Technology platform.

“Our newly approved dermatology indication opens two interesting new markets to Oculus — atopic dermatitis, which afflicts 15 million U.S. patients, and radiation dermatitis, with over one million U.S. patients. The use of the proprietary Microcyn Technology for these challenging skin afflictions is truly a unique approach and adds both depth and breadth to Oculus’ dermatology product portfolio,” said Hoji Alimi, founder and CEO of Oculus. “And in line with our business strategy, we plan to partner this new indication at the earliest for faster commercialization.”

About Radiation Dermatitis:

Radiation dermatitis is an unintended and often unavoidable skin reaction commonly experienced by patients receiving radiation therapy as part of their cancer treatment. This side effect, caused by radiation passing through skin cells, is often unpleasant and painful and may contribute to poor quality of life in cancer patients. In some cases, radiation dermatitis may become so severe as to necessitate interruption or cessation of radiation therapy.

About Atopic Dermatitis

More than 15 million patients have symptoms of atopic dermatitis, characterized by itchy skin, which can lead to rash, redness, swelling, crusting and scaling. The disease affects up to 20 percent of infants and young children, who continue to have symptoms as adults with significant impact on their quality of life. The exact cause is unknown, but genetics are considered a key factor.

More about OCLS at: www.oculusis.com

http://crwewallstreet.com/img/line1.png

Tibco Software, Inc. (Nasdaq:TIBX) announced that TIBCO ActiveMatrix BusinessWorks™ has achieved Evaluation Assurance Level 2 (EAL2) Common Criteria (NYSE:CC) certification. The certification acknowledges that ActiveMatrix BusinessWorks™ adheres to the International Standards Organization (ISO) 15408 standard recognized by 26 nations, and required for selling into the U.S. government sector.

TIBCO Software Inc. provides infrastructure software solutions in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and Japan. The company offers its products in the areas of service-oriented architecture (NYSE:SOA), business optimization, and business process management (BPM).

http://crwewallstreet.com/img/line1.png

Paychex Inc. (Nasdaq:PAYX) announced the appointment of two new vice presidents. Andrew B. Childs has been named vice president of marketing, a newly created position for the company. Laurie L. Zaucha has been named vice president of human resources and organizational development. She succeeds Will Kuchta, who has announced plans to retire this year. The Paychex Board of Directors has also appointed both new vice presidents officers of the company.

Paychex, Inc., together with its subsidiaries, provides payroll, human resource, and benefits outsourcing solutions for small- to medium-sized businesses in the United States and Germany. Paychex, Inc. was founded in 1971 and is headquartered in Rochester, New York.

http://crwewallstreet.com/img/line1.png

American Superconductor Corporation (Nasdaq:AMSC) a global power technologies company, reported record financial results for the third quarter of its fiscal year 2010 ended December 31, 2010. Revenues for the third quarter of fiscal 2010 increased 42 percent to $114.2 million from $80.7 million for the third quarter of fiscal 2009. Gross margin for the third quarter of fiscal 2010 was 40.7 percent, which compares with 37.5 percent for the third quarter of fiscal 2009.

American Superconductor Corporation, a power technologies company, provides wind turbine designs and electrical control systems primarily in North America, Europe, and the Asia-Pacific. American Superconductor Corporation was founded in 1987 and is headquartered in Devens, Massachusetts.

*******************************************
Sign-Up For Free Stock Alerts At http://crwepicks.com/signup
*******************************************

business Card 3

 

******************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.The CRWEPicks.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer (http://crwepicks.com/disclaimer ) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEPicks.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. ( read more at http://crwepicks.com/disclaimer ) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings, Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings, Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings, Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings, Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (OTCPK:CRWE) has received 3,000,000 shares of (144) restricted common stock from the company and anticipates receiving 3,000,000 shares of free trading shares from a third party for six months of advertisement services for National Health Partners Inc. (OTC:NHPR).